SF 2480 (Iowa) — Summary
Overview
- Purpose: This bill expands the regulation and taxation of nicotine products by adding nicotine analogs to the definitions of “alternative nicotine product” and “vapor product,” and imposing new excise taxes on distributors or users. It also dedicates a portion of tax revenues to the Health Care Trust Fund for pediatric cancer research and related programs, with an annual appropriation to the state Board of Regents beginning in FY 2027-2028.
- Jurisdiction: Iowa
- Session: 2025-2026
- Status: Passed in committee (Ways and Means) as of April 2026; moving through the legislative process.
Key Provisions
1) Definitions
- Adds “nicotine analog” to the definitions of:
- Alternative nicotine product
- Vapor product
- Rationale: Brings products that affect the central nervous system and are substantially similar to nicotine within the scope of regulation and taxation.
2) Taxation of Distributors
- Alternative nicotine products:
- New tax: 5 cents per container, applied to containers with up to 20 units.
- For containers with more than 20 units, a proportionate tax per unit applies (same rate, 5 cents per unit).
- Vapor products:
- New tax: 5 cents per milliliter of nicotine in a solution, plus a proportionate tax on any fractional milliliters.
- Tax base: Net volume of the nicotine solution as listed by the manufacturer.
- Payment responsibility: Tax is imposed on the distributor of the product.
3) Alternative Approach — Tax on Use/Storage
- In lieu of or in addition to distributor taxation, the bill allows the tax to be imposed on use or storage of the products (alternative nicotine products or vapor products) at the same rate as the distributor tax, if the distributor has not paid the tax.
4) Revenue Allocation and Use
- All revenues from these taxes are deposited into the Health Care Trust Fund (Code section 453A.35A).
- Beginning in FY 2027-2028 and each subsequent fiscal year:
- Not more than $3 million of the taxes attributable to the additional taxes on alternative nicotine products or vapor products shall be appropriated to the State Board of Regents.
- Purposes specified: Pediatric cancer research, clinical therapy access, and leadership for physician-scientist roles at the University of Iowa Stead Family Children’s Hospital.
5) Reporting Requirement
- The State Board of Regents must file an annual report related to the appropriation and program outcomes.
Potential Impacts
- Consumer and market impact:
- Higher costs for distributors of alternative nicotine products and vapor products due to new 5-cent-per-container/milliliter taxes.
- Possible pass-through effects to retailers and consumers, depending on market dynamics and competition.
- Public health and research impact:
- Increased dedicated funding for pediatric cancer research and related clinical programs through the Health Care Trust Fund.
- Enhanced physician-scientist leadership at the University of Iowa Stead Family Children’s Hospital.
- Administrative impact:
- New reporting and compliance requirements for manufacturers and distributors to determine net volume and proper tax calculation.
- Regular annual reporting by the Board of Regents to track the use and outcomes of the appropriations.
Timeline and Procedural Notes
- Referred to Ways and Means on April 13, 2026; subcommittee meetings and hearings held April 13-14, 2026.
- Committee and subcommittee recommendations: passage (April 14-15, 2026).
- If enacted, enforcement and collections would begin according to its effective dates (not specified in the excerpt; assume operative upon enactment or a future effective date as provided in the full bill).
Notes
- The text provided emphasizes the tax rates, base volumes (per container and per milliliter), and the revenue-sharing arrangement with the Health Care Trust Fund and Board of Regents.
- Precise effective dates and any exemptions (e.g., for small producers, retailers, or existing contracts) are not included in the excerpt and would appear in the full bill text.
